Introduction
Wnt proteins are secreted lipid-modified molecules that bind to multiple-component receptor complexes on cell membranes. Appropriate ligation of those receptors is likely to be essential for normal blood cell formation, but is very complicated (reviewed in Staal et ). For simplicity, this review will focus mainly on the canonical Wnt pathway, which involves b-catenin (also known as cadherin-associated proteinb) and members of the T-cell factor (Tcf)/lymphocyte-enhancer binding factor (Lef) family. Non-canonical mechanisms utilize the planar cell polarity pathway and the Wnt -Ca 2 þ pathway.
In the absence of Wnt ligands bound to the Wnt receptor complex, cytoplasmic levels of b-catenin, a key player in this pathway, are kept very low by the action of a protein complex (the so-called destruction complex) that actively targets b-catenin for degradation ( Figure 1 ). This complex is composed of two negative regulatory kinases, including glycogen synthase kinase 3b (Gsk-3b) and at least two anchor proteins that also function as tumor suppressor proteins, namely Axin1 or Axin2 and APC (adenomatous polyposis coli). APC and Axin function as negative regulators of the pathway by sequestering b-catenin in the cytoplasm. Activation of this pathway by certain Wnt proteins leads to inactivation of the b-catenin destruction complex allowing its accumulation in the cytoplasm and consequent migration to the nucleus. In the nucleus, b-catenin binds to members of the Tcf/Lef transcription factor family, thereby converting them from transcriptional repressors into transcriptional activators (reviewed in Staal et al. 1 ). Recent evidence from stem cells in the intestine indicates that the membrane-proximal events are even more complex and involve another co-receptor, namely the adult stem cell markers LGR5 (or related members LGR4 and 6). 3 These molecules are receptors for R-spondin and significantly enhance Wnt signaling in the stem cell niche. 4 It will be intriguing to figure out whether these receptors function in a similar fashion in the hematopoietic system.
Genetic studies involving hematopoietic stem cells (HSCs) in mice: gain-of-function approaches
The majority of studies reported on Wnt signaling in hematopoiesis provide evidence for a crucial role of canonical Wnt signaling in hematopoiesis. 5 However, a number of studies have reported data that were interpreted to have the opposite effect, namely that there is no role for canonical Wnt signaling in hematopoiesis. As we discuss here, most of these controversies can be explained by taking Wnt dosage into account.
In studies reporting an important role for Wnt signaling in blood and immune cell, Wnt signaling seemed to be required for normal HSC self-renewal and therefore for efficient reconstitution after transplantation. The role of Wnt signaling pathways in HSCs has been studied using both gain-and loss-of-function approaches. 1, 5 The first few studies on a role of Wnt signaling in the hematopoietic system focused on loss-of-function models during T-lymphocyte development in the thymus 6, 7 and have been extensively reviewed before. 8 Studies on HSCs followed a few years later and initially used gain-of-function approaches. Initial attempts to retrovirally overexpress a constitutively active form of b-catenin in Bcl2-transgenic hematopoietic stem/ progenitor cells led to an increase in the proliferation of HSCs and repopulation capacity upon transplantation into lethally irradiated mice. 9 However, conditional overexpression of a stabilized form of b-catenin using a transgenic approach led to a block in multilineage differentiation, and a transient expansion of the HSC pool, which was followed by the exhaustion of longterm HSCs. 10, 11 These and other studies have created confusion concerning the importance of Wnts in maintaining the numbers and integrity of HSCs. Recent findings suggest that this results from the differences in levels of Wnt signaling achieved in experimental circumstances. Wnts are normally present in carefully controlled gradients within tissues, and responses to them can be concentration dependent. For example, studies with reporter strains of mice suggest that levels of canonical Wnt signaling are particularly high in gut and skin, whereas lower levels are present in breast and central nervous system and even more modest levels are found in hematopoietic organs (reviewed in Grigoryan et al. 12 and Aoki and Taketo 13 and references therein). We recently showed that an optimal activation level for Wnt signaling exists in vivo; that is, when Wnt signaling is slightly enhanced over normal levels, HSC reconstitute better. However, when HSC are forced to undergo high levels of Wnt signaling, they completely fail to reconstitute irradiated recipient mice.
14 For these studies, a series of transgenic mouse lines carrying different combinations of targeted mutations of the negative Wnt signaling regulator APC were used. By combining different targeted hypomorphic alleles and a conditional deletion allele of Apc, a gradient of five different Wnt signaling levels was obtained in vivo.
15 Strict limiting-dilution competitive transplantation assays demonstrated enhanced HSC activity with activation of this pathway. Figure 1 Simplified scheme of canonical Wnt signal transduction. In the absence of Wnt signaling, free cytoplasmic b-catenin is kept at very low levels through proteosomal degradation. b-catenin degradation is accomplished through active phosphorylation at conserved regions by the ser/thr kinases Gsk-3b and Casein Kinase 1 (Ck1). These proteins belong to the so-called destruction complex, which also includes the scaffolding proteins axis inhibition protein 1 and 2 (Axin1 and Axin2) and the tumor suppressor protein APC. b-catenin is phosphorylated first on Ser45 by Ck1, and then on Ser33, Ser37 and Thr41 by Gsk-3b to create recognition sites for the ubiquitin ligase b-transducin repeat-containing protein (b-Trcp), leading to its ubiquitylation and subsequent proteasomal breakdown. At the cell membrane, upon binding of a Wnt protein to the frizzled receptor and the co-receptor low-density lipoprotein receptor-related protein 5 (Lrp5) or Lrp6, the signaling cascade is initiated. Formation of the Frizzled -Lrp5/Lrp6 complex results in the inhibition of ser/thr kinases. This inhibition, mediated by Dishevelled (Dlv), disrupts the destruction complex and allows the stabilization of b-catenin in the cytoplasm. Accumulation of b-catenin, most probably in its amino-terminally dephosphorylated form, is followed by translocation to the nucleus where it binds to Tcf/Lef transcription factors. Tcf normally assembles a transcriptional repressor complex. Formation of the active b-catenin/Tcf transcription-factor complex culminates in the activation of Wnt target genes.
SPOTLIGHT
However, HSCs only tolerated mild levels of Wnt signaling, corresponding to approximately two to threefold higher than the normal physiological levels. Both intermediate and high levels of Wnt signaling activity resulted in the inability of HSC to repopulate recipient mice. Thus, different levels of activation of the pathway can account for discrepancies in previous studies.
Furthermore, recent studies with APC haploinsufficiency, 16 
Apc
Min/ þ 17 mice or a short hairpin RNA approach to knockdown Gsk-3b activity 18 showed enhanced HSC repopulation activity. These treatments probably resulted in relatively low levels of Wnt activity. In some cases, reduced long-term reconstitution capacity was observed, despite initial increased repopulation efficiency in primary recipients. 19 Genetic studies involving HSC in mice: loss-of-function approaches Experimental approaches involving conditional deletion of b-catenin should be complementary to the over-expression studies, but again the results were confusing. For example, the Mx-Cre system has been used to drive deletion of b-catenin, 20 or both b-catenin and its homolog g-catenin.
21,22 However, no defects were observed in HSC function or cells within lymphopoietic tissues, such as the thymus. Surprisingly, in vivo reporter assays revealed that the canonical Wnt signaling pathway was still active in HSCs despite the absence of both b-and g-catenin. This could imply the existence of an alternative factor with the ability to transduce Wnt signals in the hematopoietic system. Alternatively, a hypomorphic allele of b-catenin may have been generated by the targeting approach that could theoretically permit low levels of Wnt signaling, which would negate hematopoietic defects. Support for this notion comes from recent studies on the role of b-catenin in mature CD8 þ T cells. 23 The EOMES gene is a known Wnt target gene in CD8 T cells and can be induced by Wnt3a stimulation. In T cells with the same conditionally deleted b-catenin as used in HSC (but now targeted with a mature T-cell-specific Cre promoter), the Wnt-induced activation of EOMES was significantly reduced, but not to zero (from B6 fold to B2 fold). Extrapolating this to the known remaining Wnt signaling in the two studies using conditionally deleted b-catenin (in a g-catenin-negative background) would suggest that the remaining low amount of Wnt activity could have been sufficient to sustain HSC and progenitor cells. Indeed, the deletion of b-catenin resulted in 70% 21 or 25% (Dr F Radtke, personal communication) residual Wnt activity in HSCs. Together with studies in which Wnt activity in HSC was reported to be close to zero, 24, 25 these findings suggest that complete absence of Wnt signaling is detrimental to HSC function, but that up to a quarter of normal activity is sufficient for normal function; slightly (two to threefold) enhanced Wnt activity is beneficial for HSC function, whereas higher and much higher levels abrogate HSC function. It will be of importance to verify the various explanations for the lack of effect of targeting b-catenin in blood cells experimentally.
In contrast to these results targeting b-catenin, three other loss-of-function studies indicated that some level of Wnt signaling is necessary for normal HSC function. These used Wnt3a-deficient mice, 26 overexpression of the Wnt-negative regulator DKK1 in osteoblastic stem cell niches 25 or Vav -Cremediated (rather than Mx -Cre) conditional deletion of b-catenin. 19 Because of their importance, each of these approaches will be reviewed separately.
Striking morphological similarities between Tcf1/Lef1 double deficient and Wnt3a-deficient embryos 27, 28 suggested that Wnt3a has non-redundant roles in several developmental processes. 29, 30 Using mice with a specific germline mutation in the Wnt3a gene, we showed that Wnt signaling and more specifically Wnt3a is essential for the self-renewal of fetal liver HSCs. 26 Importantly, Wnt3a deficiency could not be compensated by the other Wnt proteins expressed in fetal liver and resulted in the complete inhibition of the canonical Wnt signaling pathway. 24 This represents evidence that Wnt3a has a non-redundant role in the formation or maintenance of fetal HSC.
Wnt signaling has also been implicated in the regulation of constituent cells of the stem cell niche 31 and more specifically in maintaining osteogenic development. 32 -35 Furthermore, Wnt regulates the expression of VCAM-1 adhesion molecule by hematopoiesis-supporting stromal cells. 31 Although an indirect influence of Wnt3a on fetal HSC niches is possible, Wnt reporter analysis demonstrated that HSCs are directly affected by Wnt3a deficiency. 24 Moreover, given that Wnt3a is not expressed by the HSCs themselves, this environmentally determined deficiency turned into a cell-autonomous defect as these cells lost long-term reconstitution capacity of wild-type recipient mice, where Wnt3a is available. 36 This indicates that Wnt signaling deficiency permanently and irreversibly impairs the self-renewal capacity of HSCs.
Evidence for an essential requirement of canonical Wnt signaling for adult HSCs was also obtained with another experimental strategy by Fleming and colleagues. 25 Transgenic mice overexpressed the Wnt inhibitor DKK1 specifically in osteoblast-like cells within the bone marrow, sites thought to be part of HSC niches. Although the effects of this manipulation on HSC were subtle, serial transplantation experiments demonstrated that their self-renewal potential was compromised.
This notion was confirmed in another study using the VavCre system to achieve the deletion of b-catenin 19 in HSCs. This study also showed reduced self-renewal capacity, suggesting the requirement of Wnt signaling for the long-term growth and maintenance of HSCs.
Together these studies show that transient inhibition of the Wnt pathway during fetal development or in the adult bonemarrow niche irreversibly impairs HSC self-renewal. A possible explanation for this irreversibility may involve epigenetic modifications as a result of the absence of Wnt activation.
Other Wnt ligands and signaling pathways
Besides Wnt3a, other Wnt proteins such as Wnt5a and Wnt4 were recently implicated in the regulation of hematopoietic stem/ progenitor cells. Wnt4 expanded early hematopoietic progenitors through the activation of non-canonical Wnt signaling. 37 Intraperitoneal administration of Wnt5a into NOD/SCID mice 38 and in vitro Wnt5a exposure before transplantation 39 enhanced HSCs' repopulation capacity. Of interest is that the non-canonical Wnt5a signals may antagonize canonical Wnt signaling in HSCs. However, the results do not discriminate whether this antagonistic effect is due to the interaction of the intracellular pathways or just due to the competition between Wnt ligands for the same Frizzled receptor. Clearly, there are many possibilities for Wnt-dependent interactions between HSC and their niche microenvironment, leading to autocrine and paracrine effects in the HSC niche. 40 As discussed above, with transgenic expression of DKK1, specifically in osteoblasts, HSC self-renewal was severely diminished. 25 However, also the niche itself was severely altered, with a reduction in trabecular bone volume. Similarly, in mice deficient for a natural inhibitor of both canonical and non-canonical Wnt signaling, the Sfrp1 gene, a self-renewal defect has been reported that was dependent on the mirco environment. 41 Recently, Moore and Lemischka 42 using another natural Wnt inhibitor, namely Wif1, also showed alteration in both the niche cells and HSCs. Wif-transgenic mice showed normal numbers of HSC, but under stress conditions self-renewal was impaired and HSC quiescence was lost. Of interest, not only was Wnt signaling disturbed in the niche cells but also several other key developmental signals implicated in HSC biology were altered. These include sonic hedgehog signaling and to some extent Notch signaling. The Notch and Hedgehog pathways have extensively been described in other reviews in this spotlight series. 43, 44 Thus, alterations in one important self-renewal pathway not only affect that specific pathway but also other pathways implicated in the biology of HSC (either self -renewal, integrity, quiescence or apoptosis).
Wnt signaling in the HSC niche

Wnt signaling regulates other aspects of hematopoiesis in a dosage-dependent manner
Besides a role in the regulation of HSC function, Wnt signaling has also been implicated in differentiation through the different hematopoietic lineages. One excellent example is in T-cell development, where its role was first described. 7 In line with the idea that fetal and leukemic stem cells (LSCs) may require higher Wnt activity than normal adult HSCs, the impaired T-cell development found with conditional deletion of b-catenin in the T-cell lineage 45 also suggests that thymocyte development requires higher levels of Wnt signaling than HSC or myeloid cells. Supporting this idea, the measurement of Wnt signaling activity with in vivo reporter assays showed a remarkable difference between bone marrow stem/progenitor cells and thymocytes (approximately fivefold higher in thymocytes 14 ) and also significant changes in Wnt reporter-positive cells in various hematopoietic subpopulations. Within HSCs, the long termHSCs have the highest percentage of reporter activity, with multipotent progenitor cells having the lowest; also common myeloid progenitors and granulocyte -macrophage progenitors show significant levels and percentage of Wnt-positive cells (Figure 2 ). Both early myeloid and B-cell progenitors display detectable levels of Wnt-signaling activity, which is downregulated as these cells differentiate to more mature stages. The thymus is, of all hematopoietic organs, most rich in the expression of Wnt components 46 and also has the highest levels of Wnt signaling. Of interest, all mature blood cells show no detectable Wnt-reporter activity, with the exception of T lymphocytes. The functional importance of this finding is subject of intense research by various laboratories around the world.
Using the targeted approach of the APC tumor suppressor gene, our recent study 14 also provides evidence for an essential and dosage-dependent regulation of hematopoiesis by Wnt signals. A differential optimum of Wnt-signaling activation was observed in HSCs, myeloid development and early thymocytes, with HSCs having the lower requirements and early thymocytes having the highest ones. Importantly, very high Wnt signaling impaired both HSC self-renewal and differentiation through different hematopoietic lineages (Figure 3 ). Artificial stimulation of canonical Wnt pathways confers multilineage differentiation potential on lymphoid and myeloid progenitors. 47 Also, exposure to Wnt3a-producing stromal cells caused reacquisition of some stem cell-like characteristics by committed lymphoid progenitors. 48 These observations raise the interesting possibility that early differentiation events may be reversible and Wnt signaling is important for the maintenance of stem cell properties. This is consistent with the fact that Wnt3a helps promote the establishment of induced pluripotent stem cell lines from adult tissues. 49, 50 While Wnt3a blocks Blymphoid lineage progression in mice and humans, it is promoted by the non-canonical ligand Wnt5a. 51, 52 These effects are yet to be studied with respect to required levels of Wnt signaling.
SPOTLIGHT
Canonical Wnt signaling has also been implicated in the selfrenewal of other stem cell compartments in the gut, mammary gland, skin and embryonic stem cells. Notably, Wnt signaling influences the capacity of embryonic stem cells to differentiate into the three main germ layers: ectoderm, mesoderm and definitive endoderm, in a dosage-dependent manner. 53 These Wnt dosage-dependent effects also seem to hold true for adult self-renewing tissues, such as gut and skin, though the underlying cellular and molecular mechanisms still remain poorly understood. 54 In addition, different levels of activation of the pathway confer varying degrees of tumor susceptibility in different tissues. 55 It will be important to study whether hematopoietic malignancies where Wnt signaling is involved also have different and specific requirements of Wnt-signaling strength. Finally, as particular Wnt family molecules could be implicated in some of these processes, they may represent candidates for new therapeutic approaches.
Interactions of Wnt signals with other key developmental pathways to regulate HSCs
In addition to the regulation of hematopoiesis by means of levels, timing and duration of Wnt signals, the outcome may be determined by the cellular context in which these signals are received. This may partially be explained by other signaling pathways activated at the same time. Indeed Wnt and Notch, as well as other signaling pathways such as Hedgehog, were previously shown to synergistically or antagonistically regulate each other. 56 -58 The recent work on Wif1 transgenics underscores how closely linked these pathways are. 42 It has been proposed that Wnt and Notch signaling affect each other in regulating HSCs. 57 However, the molecular and/or biochemical mechanisms underlying these processes are still poorly understood. Gsk-3b is a potential candidate to mediate this cross talk as it regulates the stability/degradation of both b-catenin and N ICD , 59 and its inhibition affects HSC function through mechanisms involving the regulation of both Wnt and Notch target genes. 60 In addition, Jagged1 is a Wnt/b-catenin target gene in other systems, 61 implying that a cross talk involving these pathways may occur between neighboring cells.
Aberrant Wnt signaling in leukemias
Over the last couple of years it has become apparent that deregulated Wnt signaling is important in the development of hematological malignancies. Although the underlying mechanisms are sometimes unclear, mutations leading to overexpression of Wnt genes or mutations in key Wnt-signaling molecules appear to be important. Also epigenetic changes in Wnt molecules have been reported, although the functional consequences for Wnt signaling and leukemogenesis remained unclear. 62, 63 Methylation of Wnt antagonists has prognostic relevance in acute myeloid leukemia (AML). 64 Secreted frizzledrelated protein genes (sFRPs), have been found to be inactivated by promoter hypermethylation in acute lymphoblastic leukemia and AML. 65 In Chronic Myeloid Leukemia caused by the t(9,22) translocation leading to the production of the abnormal BCR -ABL fusion protein, Wnt signaling is activated during blast crises. 66 The reasons for this abnormal Wnt signaling are unknown. As discussed above, b-catenin deletion significantly reduced chronic myeloid leukemia development in murine models, 19 and deletion of MLL-AF9 or HoxA9 and Meis1a induced AML. 67 In addition, in treatment-insensitive BCR -ABL þ chronic myeloid leukemia, b-catenin is crucial to the survival of leukemic cells. 68 As AML is characterized by aberrant Wnt activation, 67, 69 this raises the interesting possibility that Wnt confers stem cell properties on the LSCs. 70 Therefore, similarly to HSCs in embryos, LSCs may have a higher requirement of Wnt activity than adult HSC in bone marrow.
This idea is further supported by recent work on AML stem cells in a MLL-AF9 leukemia model in mice. In this study by Williams and coworkers, 71 normal HSC, LSC and pre LSCs are identified. Pre LSCs contain immortalized HSC and progenitors with self-renewal properties and the ability to give rise to leukemia, depending on secondary mutational hits. In fullblown AML samples (both in mouse and human) cell-intrinsic Wnt signaling is well established, 72 but pre LSCs and HSCs are dependent on and under control of niche-derived Wnt signals.
Using the DKK1 transgenic model, the investigators show that the LSC occupy a distinct niche than HSC, 71 with different dosages of external Wnt signals.
Also in models for T-acute lymphoblastic leukemia, thymusspecific expression of activated b-catenin leads to the development of thymic lymphomas. 73 This work in mouse models has to be extended to cohorts of patients with rigorous assessment of the status of the Wnt pathway to indicate whether deregulated Wnt signaling is a causative factor in human leukemias as SPOTLIGHT Figure 3 Differential optimum of Wnt signaling strength in HSCs and early myeloid and T-cell progenitors. The graph displays the effects of increasing Wnt signaling above normal levels. For each cell lineage investigated (HSC, myeloid progenitors and thymocytes) a different optimal level of Wnt-signaling activation was observed. It is possible that at the high end of Wnt signaling, not only loss of integrity and apoptosis are induced but also a pre leukemic stage, for instance by inducing self-renewal properties on cell types normally lacking this property.
well. 74 In summary, current evidence suggests that Wnt signaling is capable of conferring stem cell properties on LSCs. 75 Thus, targeting aberrant Wnt signaling may be a means to directly affect LSCs, in contrast to most conventional chemotherapy that often is less affective at targeting leukemia-initiating cells than the bulk of the malignant cells.
Concluding remarks
HSC self-renewal, specification, commitment and differentiation are complex processes regulated by intricate networks of signals and transcription factors that have to be tightly orchestrated. It has been a long-standing challenge to mimic the niche signals that HSCs receive in order to expand and manipulate them for clinical purposes. Such clinical applications not only refer to HSCS but also to induced pluripotent stem cells differentiated into blood cells. 76 The possibility of achieving these goals by stimulating HSCs with signaling ligands such as Wnt is very attractive. 76 However, changes in delicate balances between these factors may lead to leukemia, 77 immunodeficiencies or autoimmunity. Unraveling these mechanisms will therefore be essential to fully explore the potential of HSCs and translate this basic knowledge into clinical applications. The deregulation of Wnt signaling as a causative factor in leukemogenesis is becoming more and more apparent, especially in leukemic model systems in the mouse. Given that many pharmacological small-molecule inhibitors of Wnt signaling are being tested, these developments open up new therapeutic strategies that target aberrant Wnt signaling in hematological malignancies. 78 
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